Demo of a Platform That Supports Continuous Performance Improvement by Integrating Performance Assessment, Metric-Focused Interventions, Incentives, and Community to Improve Heath Care Quality

Simone Karp* Simone Karp*,, Inc., Pittsburgh, United States

Track: Business
Presentation Topic: Web 2.0 approaches for clinical practice, clinical research, quality monitoring
Presentation Type: DEMO Interactive Session
Submission Type: Single Presentation

Building: LKSC Conference Center Stanford
Room: Lower Auditorium 120
Date: 2011-09-18 01:00 PM – 02:30 PM
Last modified: 2011-08-15

If you are the presenter of this abstract (or if you cite this abstract in a talk or on a poster), please show the QR code in your slide or poster (QR code contains this URL).


CECity’s AVEDIS system is a platform that supports a holistic approach towards Continuous Performance Improvement across the healthcare continuum, including individual providers, cross functional teams, and disparate organizations. Through the alignment of Performance, Learning, and Incentives, the AVEDIS platform is being used to deliver programs in support of various healthcare models with a focus on improvement. Programs being deployed through AVEDIS are supporting shared risk models, such as Accountable Care Organizations, and other initiatives such as Pay For Performance Programs, Quality Designation Programs, Professionalism Programs such as Maintenance of Certification and others. Additionally, the AVEDIS system provide tools which facilitate data collection from multiple sources, including web-based chart abstraction (retrospective), registries (prospective), and integrated data feeds from 3rd party database systems (EMR, Health Plan, etc.).
In the proposed presentation, you will see how the AVEDIS platform, branded as ASPIRE, is being used to support the Pennsylvania Collaborative by integrating continuous performance assessment with metric-focused interventions to improve medication adherence for health plan members. More than 90% of the estimated 3.5 billion annual prescriptions are written to treat leading chronic diseases, yet up to 75% of patients report not taking their medications as prescribed, including millions who do not take them at all. To address this issue, the Pennsylvania Collaborative initiated a scalable model for performance assessment with links to focused interventions to close the practice gaps and improve upon patient compliance and adherence for chronic conditions. The Collaborative, consisting of Highmark BCBS, Rite Aid Pharmacy, and the University of Pittsburgh School of Pharmacy, each have specific roles and responsibilities in this initiative. The goal of this work is to demonstrate the impact of targeted interventions to produce measurable improvements in medication adherence. Studies suggest that improvements in medication adherence would in turn produce quantifiable decreases in treatment costs.
This presentation will explore continuous data aggregation and evaluation of medication use metrics for health plan members; the usage and effectiveness of quality reporting, assessment and impact of dynamically linking to interventions for performance improvement to quality measure gaps; the use of web-based performance improvement platform to scale and spread performance assessment, reporting and improvement across disparate partners; the cost effectiveness of the improvement interventions and discussion of potential performance-based incentive reimbursement strategies to be considered by health plans; the evaluation of the cost effectiveness of the medication adherence improvement program; and the impact of the cost and satisfaction of health plan members.

Medicine 2.0® is happy to support and promote other conferences and workshops in this area. Contact us to produce, disseminate and promote your conference or workshop under this label and in this event series. In addition, we are always looking for hosts of future World Congresses. Medicine 2.0® is a registered trademark of JMIR Publications Inc., the leading academic ehealth publisher.
Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.